293 related articles for article (PubMed ID: 21853991)
1. Structural modification of honokiol, a biphenyl occurring in Magnolia officinalis: the evaluation of honokiol analogues as inhibitors of angiogenesis and for their cytotoxicity and structure-activity relationship.
Ma L; Chen J; Wang X; Liang X; Luo Y; Zhu W; Wang T; Peng M; Li S; Jie S; Peng A; Wei Y; Chen L
J Med Chem; 2011 Oct; 54(19):6469-81. PubMed ID: 21853991
[TBL] [Abstract][Full Text] [Related]
2. Semi-synthesis and anti-proliferative activity evaluation of novel analogues of Honokiol.
Luo Y; Xu Y; Chen L; Hu J; Peng C; Xie D; Shi J; Huang W; Xu G; Peng M; Han J; Li R; Yang S; Wei Y
Bioorg Med Chem Lett; 2009 Aug; 19(16):4702-5. PubMed ID: 19589678
[TBL] [Abstract][Full Text] [Related]
3. Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish.
Tran TC; Sneed B; Haider J; Blavo D; White A; Aiyejorun T; Baranowski TC; Rubinstein AL; Doan TN; Dingledine R; Sandberg EM
Cancer Res; 2007 Dec; 67(23):11386-92. PubMed ID: 18056466
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and anti-proliferative evaluation of [1,1'-biphenyl]-4-ols as inhibitor of HUVEC migration and tube formation.
Ran Y; Ma L; Wang X; Chen J; Wang G; Peng A; Chen L
Molecules; 2012 Jul; 17(7):8091-104. PubMed ID: 22766801
[TBL] [Abstract][Full Text] [Related]
5. Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
Tang H; Zhang Y; Li D; Fu S; Tang M; Wan L; Chen K; Liu Z; Xue L; Peng A; Ye H; Chen L
Eur J Med Chem; 2018 Aug; 156():190-205. PubMed ID: 30006164
[TBL] [Abstract][Full Text] [Related]
6. Structural modification of an angiogenesis inhibitor discovered from traditional Chinese medicine and a structure-activity relationship study.
Yang SP; Cai YJ; Zhang BL; Tong LJ; Xie H; Wu Y; Lin LP; Ding J; Yue JM
J Med Chem; 2008 Jan; 51(1):77-85. PubMed ID: 18078313
[TBL] [Abstract][Full Text] [Related]
7. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models.
Hou W; Chen L; Yang G; Zhou H; Jiang Q; Zhong Z; Hu J; Chen X; Wang X; Yuan Y; Tang M; Wen J; Wei Y
Phytother Res; 2008 Aug; 22(8):1125-32. PubMed ID: 18570244
[TBL] [Abstract][Full Text] [Related]
8. Formylated honokiol analogs showed antitumor activity against lung carcinoma.
Deng S; Zhang C; Yang L; Ma L
Anticancer Drugs; 2019 Sep; 30(8):795-802. PubMed ID: 30807551
[TBL] [Abstract][Full Text] [Related]
9. Honokiol, a phytochemical from Magnolia spp., inhibits breast cancer cell migration by targeting nitric oxide and cyclooxygenase-2.
Singh T; Katiyar SK
Int J Oncol; 2011 Mar; 38(3):769-76. PubMed ID: 21225228
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of novel deguelin-based heat shock protein 90 (HSP90) inhibitors targeting proliferation and angiogenesis.
Chang DJ; An H; Kim KS; Kim HH; Jung J; Lee JM; Kim NJ; Han YT; Yun H; Lee S; Lee G; Lee S; Lee JS; Cha JH; Park JH; Park JW; Lee SC; Kim SG; Kim JH; Lee HY; Kim KW; Suh YG
J Med Chem; 2012 Dec; 55(24):10863-84. PubMed ID: 23186287
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and microbiological evaluation of honokiol derivatives as new antimicrobial agents.
Kim YS; Lee JY; Park J; Hwang W; Lee J; Park D
Arch Pharm Res; 2010 Jan; 33(1):61-5. PubMed ID: 20191344
[TBL] [Abstract][Full Text] [Related]
12. 5-Formylhonokiol exerts anti-angiogenesis activity via inactivating the ERK signaling pathway.
Zhu W; Fu A; Hu J; Wang T; Luo Y; Peng M; Ma Y; Wei Y; Chen L
Exp Mol Med; 2011 Mar; 43(3):146-52. PubMed ID: 21297378
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of honokiol against oxidized LDL-induced cytotoxicity and adhesion molecule expression in endothelial cells.
Ou HC; Chou FP; Lin TM; Yang CH; Sheu WH
Chem Biol Interact; 2006 May; 161(1):1-13. PubMed ID: 16580656
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, structure-activity relationships and biological evaluation of barbigerone analogues as anti-proliferative and anti-angiogenesis agents.
Wang G; Wang F; Cao D; Liu Y; Zhang R; Ye H; Li X; He L; Yang Z; Ma L; Peng A; Xiang M; Wei Y; Chen L
Bioorg Med Chem Lett; 2014 Jul; 24(14):3158-63. PubMed ID: 24863745
[TBL] [Abstract][Full Text] [Related]
15. Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells.
Li Z; Liu Y; Zhao X; Pan X; Yin R; Huang C; Chen L; Wei Y
Eur J Obstet Gynecol Reprod Biol; 2008 Sep; 140(1):95-102. PubMed ID: 18440692
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antiangiogenic activity of novel gambogic acid derivatives.
Chen T; Zhang RH; He SC; Xu QY; Ma L; Wang GC; Qiu N; Peng F; Chen JY; Qiu JX; Peng AH; Chen LJ
Molecules; 2012 May; 17(6):6249-68. PubMed ID: 22634837
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of anti-HIF and anti-angiogenic properties of honokiol for the treatment of ocular neovascular diseases.
Vavilala DT; Ponnaluri VK; Kanjilal D; Mukherji M
PLoS One; 2014; 9(11):e113717. PubMed ID: 25422886
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic activity of Diallyl Sulfide (DAS).
Thejass P; Kuttan G
Int Immunopharmacol; 2007 Mar; 7(3):295-305. PubMed ID: 17276887
[TBL] [Abstract][Full Text] [Related]
19. Use of a monoclonal antibody specific for activated endothelial cells to quantitate angiogenesis in vivo in zebrafish after drug treatment.
Seng WL; Eng K; Lee J; McGrath P
Angiogenesis; 2004; 7(3):243-53. PubMed ID: 15609079
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
